Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Icon Plc stock logo
ICLR
Icon
$164.51
$160.35
$66.57
$203.91
$12.60B1.21850,557 shs388,372 shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$590.67
$522.14
$373.00
$677.90
$16.49B1.15370,504 shs136,482 shs
Revvity Inc. stock logo
RVTY
Revvity
$114.81
+0.1%
$108.01
$81.22
$118.30
$12.81B1.071.54 million shs1.03 million shs
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€20.31
+0.2%
€18.80
€12.89
€28.00
€6.15B0.77362,533 shs306,400 shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Icon Plc stock logo
ICLR
Icon
0.00%+0.57%-1.91%+38.29%+3.83%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
0.00%+2.35%+9.74%+41.55%+35.99%
Revvity Inc. stock logo
RVTY
Revvity
0.00%+1.79%+2.12%+15.83%+32.04%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
0.00%+2.08%+3.46%+11.00%-13.60%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Icon Plc stock logo
ICLR
Icon
$164.51
$160.35
$66.57
$203.91
$12.60B1.21850,557 shs388,372 shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$590.67
$522.14
$373.00
$677.90
$16.49B1.15370,504 shs136,482 shs
Revvity Inc. stock logo
RVTY
Revvity
$114.81
+0.1%
$108.01
$81.22
$118.30
$12.81B1.071.54 million shs1.03 million shs
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€20.31
+0.2%
€18.80
€12.89
€28.00
€6.15B0.77362,533 shs306,400 shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Icon Plc stock logo
ICLR
Icon
0.00%+0.57%-1.91%+38.29%+3.83%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
0.00%+2.35%+9.74%+41.55%+35.99%
Revvity Inc. stock logo
RVTY
Revvity
0.00%+1.79%+2.12%+15.83%+32.04%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
0.00%+2.08%+3.46%+11.00%-13.60%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Icon Plc stock logo
ICLR
Icon
2.41
Hold$170.403.58% Upside
Medpace Holdings, Inc. stock logo
MEDP
Medpace
2.15
Hold$584.18-1.10% Downside
Revvity Inc. stock logo
RVTY
Revvity
2.20
Hold$108.36-5.61% Downside
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
3.00
BuyN/AN/A

Current Analyst Ratings Breakdown

Latest STVN, MEDP, RVTY, and ICLR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/5/2026
Revvity Inc. stock logo
RVTY
Revvity
Reiterated RatingOutperform
8/4/2026
Revvity Inc. stock logo
RVTY
Revvity
UpgradeStrong SellHold
7/31/2026
Icon Plc stock logo
ICLR
Icon
Set Price Target$194.00
7/31/2026
Icon Plc stock logo
ICLR
Icon
Boost Price TargetNeutral$165.00 ➝ $180.00
7/31/2026
Icon Plc stock logo
ICLR
Icon
Reiterated RatingBuy$207.00 ➝ $209.00
7/30/2026
Revvity Inc. stock logo
RVTY
Revvity
UpgradeSell (D+)Hold (C-)
7/30/2026
Icon Plc stock logo
ICLR
Icon
UpgradeStrong-Buy
7/30/2026
Icon Plc stock logo
ICLR
Icon
UpgradeHold
7/28/2026
Icon Plc stock logo
ICLR
Icon
UpgradeStrong SellHold
7/24/2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Boost Price TargetOutperform$484.00 ➝ $692.00
7/24/2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Boost Price TargetOutperform$586.00 ➝ $665.00
(Data available from 8/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Icon Plc stock logo
ICLR
Icon
$8.25B1.53$16.86 per share9.76$120.07 per share1.37
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$2.53B6.52$17.01 per share34.72$16.30 per share36.24
Revvity Inc. stock logo
RVTY
Revvity
$2.86B4.48$8.82 per share13.01$63.95 per share1.80
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€1.23B5.02€0.88 per share22.98€5.55 per share3.66
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Icon Plc stock logo
ICLR
Icon
$229.34M$4.2638.6215.236.823.99%8.02%4.56%10/28/2026 (Estimated)
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$451.12M$17.0634.6230.812.6317.67%110.15%24.84%10/28/2026 (Estimated)
Revvity Inc. stock logo
RVTY
Revvity
$241.20M$2.1054.6719.592.098.16%8.34%5.01%10/26/2026 (Estimated)
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€158.21M€0.5636.2625.381.7010.99%10.43%6.16%N/A

Latest STVN, MEDP, RVTY, and ICLR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/4/2026Q2 2026
Revvity Inc. stock logo
RVTY
Revvity
$1.21$1.41+$0.20$0.47$702.96 million$711.00 million
7/30/2026Q1 2026
Icon Plc stock logo
ICLR
Icon
$2.55$2.56+$0.01$0.94$2.00 billion$2.06 billion
7/22/2026Q2 2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$3.98$4.25+$0.27$4.25$689.51 million$707.33 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Icon Plc stock logo
ICLR
Icon
N/AN/AN/AN/AN/A
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/AN/AN/AN/AN/A
Revvity Inc. stock logo
RVTY
Revvity
$0.280.24%N/A13.33%N/A
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
N/AN/AN/AN/A1 Years

Latest STVN, MEDP, RVTY, and ICLR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/31/2026
Revvity Inc. stock logo
RVTY
Revvity
quarterly$0.070.25%10/23/202610/23/202611/13/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Icon Plc stock logo
ICLR
Icon
0.23
0.95
0.95
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/A
0.73
0.73
Revvity Inc. stock logo
RVTY
Revvity
0.36
1.80
1.50
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
0.21
1.61
1.08

Institutional Ownership

CompanyInstitutional Ownership
Icon Plc stock logo
ICLR
Icon
95.61%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
77.98%
Revvity Inc. stock logo
RVTY
Revvity
86.65%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
N/A

Insider Ownership

CompanyInsider Ownership
Icon Plc stock logo
ICLR
Icon
44.00%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
20.50%
Revvity Inc. stock logo
RVTY
Revvity
0.85%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
0.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Icon Plc stock logo
ICLR
Icon
40,10076.57 million42.88 millionOptionable
Medpace Holdings, Inc. stock logo
MEDP
Medpace
6,20027.91 million22.19 millionOptionable
Revvity Inc. stock logo
RVTY
Revvity
11,000111.56 million110.61 millionOptionable
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
6,010302.84 millionN/AOptionable

Recent News About These Companies

Stevanato Group Q2 Earnings Call Highlights
Stevanato Group S.p.A. Q2 2026 Earnings Call Summary
Stevanato Group S.p.A.
Stevanato: Q2 Earnings Snapshot

New MarketBeat Followers Over Time

Media Sentiment Over Time

Icon stock logo

Icon NASDAQ:ICLR

$164.51 0.00 (0.00%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$164.33 -0.18 (-0.11%)
As of 05:07 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.

Medpace stock logo

Medpace NASDAQ:MEDP

$590.67 0.00 (0.00%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$590.80 +0.13 (+0.02%)
As of 04:27 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

Revvity stock logo

Revvity NYSE:RVTY

$114.81 +0.15 (+0.13%)
Closing price 08/7/2026 03:59 PM Eastern
Extended Trading
$114.39 -0.41 (-0.36%)
As of 06:08 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Stevanato Group stock logo

Stevanato Group NYSE:STVN

€20.30 +0.04 (+0.17%)
Closing price 08/7/2026 03:59 PM Eastern
Extended Trading
€20.32 +0.01 (+0.05%)
As of 08/7/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.